Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Psychiatry
Volume 2015, Article ID 815673, 3 pages
http://dx.doi.org/10.1155/2015/815673
Case Report

Robust and Sustained Effect of Ketamine Infusions Coadministered with Conventional Antidepressants in a Patient with Refractory Major Depression

1Psychiatry Service, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, CIBERSAM, IRYCIS, Carretera Colmenar km. 9.1, 28034 Madrid, Spain
2Psychiatry Service, Hospital Universitario del Sureste, Universidad Rey Juan Carlos, Ronda del Sur 10, 28500 Madrid, Spain
3Anaesthesiology Service, Hospital Universitario del Sureste, Universidad Rey Juan Carlos, Ronda del Sur 10, 28500 Madrid, Spain

Received 22 December 2014; Accepted 23 February 2015

Academic Editor: Thomas Frodl

Copyright © 2015 José Manuel Montes et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. C. Kessler, P. Berglund, O. Demler et al., “The epidemiology of major depressive disorder: results for the National Comorbidity Survey Replication (NCS-R),” The Journal of the American Medical Association, vol. 289, no. 23, pp. 3095–3105, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. M. H. Trivedi, A. J. Rush, S. R. Wisniewski et al., “Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice,” American Journal of Psychiatry, vol. 163, no. 1, pp. 28–40, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. A. J. Rush, M. H. Trivedi, J. W. Stewart et al., “Combining Medications to Enhance Depression Outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study,” The American Journal of Psychiatry, vol. 168, no. 7, pp. 689–701, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. The UK ECT Review Group, “Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis,” The Lancet, vol. 361, no. 9360, pp. 799–808, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. M. S. Nobler, H. A. Sackeim, J. R. Moeller, J. Prudic, E. Petkova, and C. Waternaux, “Quantifying the speed of symptomatic improvement with electroconvulsive therapy: comparison of alternative statistical methods,” Convulsive Therapy, vol. 13, no. 4, pp. 208–221, 1997. View at Google Scholar · View at Scopus
  6. C. A. Zarate Jr., J. B. Singh, P. J. Carlson et al., “A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression,” Archives of General Psychiatry, vol. 63, no. 8, pp. 856–864, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Ibrahim, N. Diazgranados, D. A. Luckenbaugh et al., “Rapid decrease in depressive symptoms with an N-methyl-D-aspartate antagonist in ECT-resistant major depression,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 35, no. 4, pp. 1155–1159, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Gosek, M. Chojnacka, P. Bieńkowski, and Ł. Świecicki, “Effectiveness of ketamine in depressed patients resistant to ECT or rTMS therapy,” Psychiatria Polska, vol. 48, no. 1, pp. 49–58, 2014. View at Google Scholar · View at Scopus
  9. M. Naughton, G. Clarke, O. F. O′Leary, J. F. Cryan, and T. G. Dinan, “A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action,” Journal of Affective Disorders, vol. 156, pp. 24–35, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. P. R. Shiroma, B. Johns, M. Kuskowski et al., “Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression,” Journal of Affective Disorders, vol. 155, no. 1, pp. 123–129, 2014. View at Publisher · View at Google Scholar · View at Scopus